Restricted Loss of Life Expectancy in Patients With Acute Myocardial Infarction: A Nationwide KAMIR Registry Study
Authors:
- Jin‐Ho ChoiJCJin‐Ho Choi
- Ki‐Hong ChoiKCKi‐Hong Choi
- Joo Myung LeeJLJoo Myung Lee
- Taek Kyu ParkTPTaek Kyu Park
- Jeong Hoon YangJYJeong Hoon Yang
- Young Bin SongYSYoung Bin Song
- Joo‐Yong HahnJHJoo‐Yong Hahn
- Weon KimWKWeon Kim
- Seung‐Ho HurSHSeung‐Ho Hur
- Chang‐Hwan YoonCYChang‐Hwan Yoon
- Jin‐Yong HwangJHJin‐Yong Hwang
- 6 October 2026
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e050187
Abstract
Background: The mortality risk of acute myocardial infarction declines rapidly after the initial period, yet the quantitative measures of residual risk in the follow‐up period remain limited. We aimed to assess restricted loss of life expectancy (LOLE) in patients with acute myocardial infarction. Methods: We included patients from KAMIR (Korea Acute Myocardial Infarction Registry), a nationwide acute myocardial infarction registry, between 2012 and 2020. The survival of 27 705 patients (mean age, 64 years; 76% men) was compared with an age‐, sex‐, and calendar year–matched reference cohort derived from Korean population life tables. Three‐year restricted LOLE was estimated using a Royston–Parmar flexible parametric survival model adjusted for clinical characteristics. Results: Overall, 3‐year restricted LOLE was 23 (95% CI, 22–25) days. In subgroup analyses, older age (≥75 years, 42 [95% CI, 37–47] days versus <50 years, 7 [95% CI, 3–10] days), female sex (44 [95% CI, 37–51] days versus male sex, 14 [95% CI, 11–17] days), and lower left ventricular ejection fraction (≤40%; 135 [95% CI, 128–142] days versus ≥50%, 0 [−2 to 1] days) were associated with higher 3‐year restricted LOLE. Across the study period, 3‐year restricted LOLE nearly halved from 36 (95% CI, 31–41) to 16 (95% CI, 9–23) days. Conclusions: Restricted LOLE provides intuitive, patient‐centered measures of residual risk after acute myocardial infarction. It also demonstrated a significant improvements in patient outcomes over the study period.Keywords
This publication has 31 references indexed in Scilit:
- Early Invasive or Conservative Strategies for Older Patients With Acute Coronary SyndromesJAMA Internal Medicine, 2025
- Risk of Hematologic Malignancies in Patients With Acute Myocardial InfarctionJACC: Cardiooncology, 2025
- Time Trends in Major Adverse Cardiovascular Events After Percutaneous Coronary InterventionJACC: Advances, 2025
- Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Temporal Trends in Noncardiovascular Morbidity and Mortality Following Acute Myocardial InfarctionJACC, 2023
- Intravascular Imaging–Guided or Angiography-Guided Complex PCINew England Journal of Medicine, 2023
- 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease RiskJACC, 2022
- Life Expectancy after Myocardial Infarction, According to Hospital PerformanceNew England Journal of Medicine, 2016
- Life Expectancy and Years of Potential Life Lost After Acute Myocardial Infarction by Sex and RaceJACC, 2015
- Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effectsStatistics in Medicine, 2002